RenovoRx Common Stock

The latest common stock for RNXT is $710K as of March 2026. That compares with $940K in the prior-year period — down 24.8% year over year. Investors often review this figure alongside RenovoRx's historical trend and sector peers before judging valuation or financial health.

Over the past year, RNXT's common stock moved from $940K to $710K — a 24.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RenovoRx's operating scale or balance-sheet position.

A common stock figure of $710K for RNXT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RNXT's common stock ($710K), review year-over-year change from $940K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.